Arabic Arabic English English French French German German
dark

Public Meeting: Patient-Focused Drug Development for Neuropathic Pain (Part 2 of 3)

On June 10, 2016, FDA hosted a public meeting on Patient-Focused Drug Development for Neuropathic Pain Associated with Peripheral Neuropathy. FDA was interested in obtaining patient perspectives on the impact of neuropathic pain associated with peripheral neuropathy on daily life and patient views on treatment approaches. For more information, visit the meeting webpage: https://go.usa.gov/xHrgH

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Mass General, AstraZeneca Pilot Digital Health Program for Asthma, Heart Failure

Next Post

Al-Jouf: 5,000+ Dialysis Sessions Conducted by Dialysis Centers in 3 Months

Related Posts
Total
0
Share